AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 59,100
-5,500 (-8.51%)
At close: Feb 6, 2026
AprilBio Revenue
AprilBio had revenue of 8.97B KRW in the twelve months ending September 30, 2025, down -56.67% year-over-year. In the year 2024, AprilBio had annual revenue of 27.51B.
Revenue (ttm)
8.97B
Revenue Growth
-56.67%
P/S Ratio
153.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.38T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.51B | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 200.00M | -23.20B | -99.15% |
| Dec 31, 2021 | 23.40B | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 89.78B |
| Aimed Bio | 29.65B |
| ROKIT Healthcare | 20.33B |
| JS Link | 16.14B |
| Qurient | 8.28B |
| AbClon | 3.80B |
| IntoCell | 1.68B |
| ToolGen | 1.07B |